Cancer discovery symposium set for March 17
On March 17, the newly established Forbes Institute for Cancer Discovery will present its inaugural symposium in Ann Arbor, co-sponsored by the A. Alfred Taubman Medical Research Institute.
Four eminent speakers will discuss their latest findings in the understanding of cancer metabolism and how new research is leading to new avenues for cancer therapy.
Speakers include Michael Lisanti, MD, PhD, Chair in Translational Medicine at the University of Salford (UK); Michael Pollak, MD, Alexander-Goldfarb Research Chair in Medical Oncology, McGill University; Max Wicha, MD, Director of the Forbes Institute for Cancer Discovery, University of Michigan, and Costas Lyssiotis, PhD, Assistant Professor of Molecular and Integrative Physiology, University of Michigan. Opening remarks by Eric Fearon, MD, PhD, Director of the University of Michigan Comprehensive Cancer Center.
All welcome, no registration required. Coffee and networking at 8:00 a.m. in the lobby of the A. Alfred Taubman Biomedical Science Research Building at 109 Zina Pitcher Place, Ann Arbor, MI, 48170.
The Forbes Institute, established in 2016 with a gift from noted Michigan philanthropists Madeline and Sidney Forbes, aims to accelerate the translation of cutting-edge cancer treatment from the laboratory to patients. It is lead by Dr. Wicha, a Founding Taubman Scholar who established the U-M Compreshensive Cancer Center.
Dr. Eva Feldman: Alfred Taubman as mentor, leader, friend
The source of his greatness lay in his willingness to challenge conventional thinking.
Emerging Scholars publish new findings on basal cell cancer
Ophthalmologists Alon Kahana, MD, PhD and Rajesh Rao, MD are trying to pinpoint when the common cancer turns dangerous.
Dr. Max Wicha receives $6.5 million to target cancer stem cells
The award from the National Cancer Institute will fuel research into the cells that cause metastasis.
news & events
In the News
Taubman Emerging Scholar partners in ACL repair study
Asheesh Bedi, M.D., is an investigator in a study using human growth hormone to aid healing of the common knee injury.
Drug cuts risk of bone-marrow transplant side effect
Taubman Emerging Scholar Sung Won Choi, M.D. and team find a new way to help prevent graft-vs-host disease in cancer patients receiving bone-marrow transplants.
Arthritis drug may help diabetics with kidney disease
Research led by Taubman Scholar Frank Brosius has led to a fast-track study that shows promising results